IQVIA HOLDINGS INC.

IQV 10-Q · Q3 2025
API behind this page

IQV Q3 2025 request

Playground key active
Request URL /api/financials?ticker=IQV&year=2025&quarter=3
waiting 0 ms 
Pick an endpoint and run the request.
curl

Income Statement

JSON CSV Excel
Income Statement
Metric Q3 2025 Q3 2024 YoY
Revenue 4,100 3,896 +5.2%
Show Business Segments breakouts
Contract Sales & Medical Solutions 209 180 +16.1%
Contract Sales & Medical Solutions · Americas 70 72 -2.8%
Contract Sales & Medical Solutions · Asia Pacific 64 54 +18.5%
Contract Sales & Medical Solutions · EMEA 75 54 +38.9%
Contract Sales & Medical Solutions · Operating Segments 209 180 +16.1%
Research & Development Solutions 2,260 2,162 +4.5%
Research & Development Solutions · Americas 1,039 969 +7.2%
Research & Development Solutions · Asia Pacific 651 586 +11.1%
Research & Development Solutions · EMEA 570 607 -6.1%
Research & Development Solutions · Operating Segments 2,260 2,162 +4.5%
Technology & Analytics Solutions 1,631 1,554 +5.0%
Technology & Analytics Solutions · Americas 824 797 +3.4%
Technology & Analytics Solutions · Asia Pacific 155 131 +18.3%
Technology & Analytics Solutions · EMEA 652 626 +4.2%
Technology & Analytics Solutions · Operating Segments 1,631 1,554 +5.0%
Show Geography breakouts
Americas 1,933 1,838 +5.2%
Asia Pacific 870 771 +12.8%
EMEA 1,297 1,287 +0.8%
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax 3 11 -72.7%
Show Derivative Risk breakouts
Foreign Exchange Forward · Sales 1 3 -66.7%
Interest Rate Swap · Interest Expense 2 8 -75.0%
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax -3 -8 +62.5%
Cost Of Goods And Service Excluding Depreciation Depletion And Amortization 2,727 2,518 +8.3%
Show Business Segments breakouts
Contract Sales & Medical Solutions · Operating Segments 181 154 +17.5%
Research & Development Solutions · Operating Segments 1,532 1,442 +6.2%
Technology & Analytics Solutions · Operating Segments 1,014 922 +10.0%
Selling, General & Administrative 514 522 -1.5%
Show Business Segments breakouts
Contract Sales & Medical Solutions · Operating Segments 15 14 +7.1%
Research & Development Solutions · Operating Segments 232 222 +4.5%
Technology & Analytics Solutions · Operating Segments 247 227 +8.8%
Show Consolidation Items breakouts
Operating Segments 494 463 +6.7%
Depreciation & Amortization 286 278 +2.9%
Restructuring Charges 20 28 -28.6%
Operating Income 553 550 +0.5%
Interest Income -13 -13 0.0%
Interest Expense 189 170 +11.2%
Other Non-Operating Income (Expense) -31 44 -170.5%
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments 408 349 +16.9%
Income Tax Expense (Benefit) 76 65 +16.9%
Income Loss From Continuing Operations After Income Taxes And Before Equity In Earnings Of Unconsolidated Affiliates 332 284 +16.9%
Net Income 332 285 +16.5%
Show Equity Components breakouts
Noncontrolling Interest 1 — —
Retained Earnings 331 285 +16.1%
Net Income Loss Attributable To Noncontrolling Interest -1 — —
Net Income 331 285 +16.1%
EPS (Basic) 1.94 1.57 +23.6%
EPS (Diluted) 1.93 1.55 +24.5%
Wtd Avg Shares (Basic) 170.2 182.1 -6.5%
Wtd Avg Shares (Diluted) 171.7 184.2 -6.8%
Gross Profit (Q) — — —
Show Business Segments breakouts
Contract Sales & Medical Solutions · Operating Segments 13 12 +8.3%
Research & Development Solutions · Operating Segments 496 498 -0.4%
Technology & Analytics Solutions · Operating Segments 370 405 -8.6%
Show Consolidation Items breakouts
Corporate Non Segment -20 -59 +66.1%
Operating Segments 879 915 -3.9%
Comprehensive Income 285 408 -30.1%
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax -5 -41 +87.8%
Show Equity Components breakouts
Accumulated Other Comprehensive Income -5 -41 +87.8%

Balance Sheet

Balance Sheet
Metric Q3 2025 Q3 2024 YoY
Current Assets
Cash & Cash Equivalents 1,814 1,572 +15.4%
Trade Accounts Receivable And Unbilled Services Net 3,269 3,196 +2.3%
Prepaid Expense Current 177 195 -9.2%
Income Taxes Receivable 45 54 -16.7%
Marketable Securities (Current) 158 140 +12.9%
Show Fair Value Hierarchy breakouts
Fair Value Inputs Level1 · Fair Value Measurements Recurring 190 173 +9.8%
Show Fair Value By Measurement Frequency breakouts
Fair Value Measurements Recurring 190 173 +9.8%
Other Assets Current And Receivables 516 475 +8.6%
Total Current Assets 5,979 5,632 +6.2%
Non-Current Assets
Property, Plant & Equipment 525 513 +2.3%
Operating Lease Right-of-Use Assets 299 259 +15.4%
Goodwill 15,948 15,091 +5.7%
Show Business Segments breakouts
Contract Sales & Medical Solutions 168 152 +10.5%
Research & Development Solutions 3,032 2,625 +15.5%
Technology & Analytics Solutions 12,748 12,314 +3.5%
Show Business Acquisition breakouts
Series Of Individually Immaterial Business Acquisitions 596 470 +26.8%
Deferred Tax Assets 390 164 +137.8%
Deposits And Other Assets Noncurrent 474 467 +1.5%
Total Assets 28,727 27,180 +5.7%
Other Assets
Long Term Investments Excluding Equity Method Investments 130 117 +11.1%
Equity Method Investments 275 203 +35.5%
Intangible Assets Net Excluding Goodwill 4,707 4,734 -0.6%
Show Fair Value Hierarchy breakouts
Fair Value Inputs Level3 · Fair Value Measurements Nonrecurring 4,707 4,734 -0.6%
Current Liabilities
Accounts Payable And Other Accrued Liabilities Current 3,550 3,434 +3.4%
Deferred Revenue (Current) 2,160 1,824 +18.4%
Accrued Income Taxes Current 119 161 -26.1%
Current Portion of Long-Term Debt 2,164 1,219 +77.5%
Other Liabilities Current 515 354 +45.5%
Total Current Liabilities 8,508 6,992 +21.7%
Non-Current Liabilities
Long-Term Debt 12,793 12,293 +4.1%
Deferred Tax Liabilities 207 128 +61.7%
Operating Lease Liabilities 233 188 +23.9%
Other Non-Current Liabilities 698 612 +14.1%
Total Liabilities 22,439 20,213 +11.0%
Long-Term Debt (Q) — — —
Show Debt Instrument breakouts
Net Investment Hedging · Designated As Hedging Instrument 2,922 2,564 +14.0%
Stockholders' Equity
Common Stocks Including Additional Paid In Capital 11,321 11,106 +1.9%
Retained Earnings 6,911 5,628 +22.8%
Treasury Stock Common Value -11,144 -8,941 -24.6%
Accumulated Other Comprehensive Income -928 -826 -12.3%
Total Stockholders' Equity 6,160 6,967 -11.6%
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment 11 2 +450.0%
Accumulated Gain Loss Net Cash Flow Hedge Parent -44 -62 +29.0%
Accumulated Other Comprehensive Income -928 -826 -12.3%
Accumulated Translation Adjustment -1,092 -894 -22.1%
Minority Interest 128 — —
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 6,288 6,967 -9.7%
Show Equity Components breakouts
Accumulated Other Comprehensive Income -928 -826 -12.3%
Additional Paid In Capital 11,318 11,103 +1.9%
Common Stock 3 3 0.0%
Noncontrolling Interest 128 — —
Retained Earnings 6,911 5,628 +22.8%
Treasury Stock Common -11,144 -8,941 -24.6%
Total Liabilities & Equity 28,727 27,180 +5.7%

Cash Flow Statement

Cash Flow Statement
Metric YTD Q3 2025 YTD Q3 2024 YoY
Operating Activities
Amortization Of Financing Costs And Discounts 17 16 +6.2%
Stock-Based Compensation 187 158 +18.4%
Income Loss From Equity Method Investments Net Of Dividends Or Distributions 14 — —
Gain Loss On Sale Of Investments -20 -29 +31.0%
Deferred Income Taxes -132 -114 -15.8%
Increase Decrease In Accounts Receivable Unbilled Services And Unearned Income 442 259 +70.7%
Increase Decrease In Other Operating Capital Net -263 -206 -27.7%
Net Cash from Operations 1,919 1,831 +4.8%
Change in Deferred Revenue 381 25 +1424.0%
Investing Activities
Payments To Acquire Productive Assets -429 -438 +2.1%
Payments To Acquire Businesses Net Of Cash Acquired -798 -649 -23.0%
Payments For Proceeds From Investments 2 — —
Payments To Acquire Equity Method Investments And Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital -28 -68 +58.8%
Payments For Proceeds From Investments Excluding Marketable Securities -20 -2 -900.0%
Proceeds From Sale Of Property Plant And Equipment 75 25 +200.0%
Other Investing Activities -3 -2 -50.0%
Net Cash from Investing -1,201 -1,134 -5.9%
Financing Activities
Proceeds From Issuance Of Debt 3,985 — —
Debt Issuance Costs -34 — —
Repayments Of Debt And Capital Lease Obligations -2,676 -130 -1958.5%
Proceeds From Lines Of Credit 1,375 685 +100.7%
Repayments Of Lines Of Credit -2,200 -785 -180.3%
Payments For Stock Options Exercised -66 -61 -8.2%
Share Repurchases -1,032 -200 -416.0%
Payment For Contingent Consideration Liability Financing Activities -26 -12 -116.7%
Proceeds From Payments For Other Financing Activities -11 — —
Net Cash from Financing -685 -503 -36.2%
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 79 2 +3850.0%
Net Change in Cash 112 196 -42.9%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 1,814 1,572 +15.4%

Values in millions USD. Source: SEC EDGAR 10-Q filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key